Localized Gingival Recession
Conditions
Brief summary
Can a fetal bovine derived membrane serve as an alternative to autogenous tissue for dental root coverage procedures.
Detailed description
PriMatrix (TEI Medical Inc) is a promising collagen membrane derived from fetal bovine dermis. The acellular porous structure of the membrane permits rapid re-vascularization and cellular re-population. The membrane contains a high proportion of type III collagen. Type III collagen helps regulate tissue healing by promoting neoepithelialization and angiogenesis. Wounds grafted with PriMatrix exhibited significantly faster healing rates compared to control wounds while having a minimal foreign body response and early repopulation by progenitor cells. The ability of PriMatrix to permit neovascularization, reepithelialization, minimal immune response, and population by progenitor cells suggests that it may serve as an ideal alternative to CTG under CPF for root coverage. In this regard, the current study aims to serve as a pilot to test the feasibility of the use of PriMatrix as a graft material under a CPF to attain root coverage of Miller Class I & II defects.
Interventions
DEVICEPriMatrix
Use of PriMatrix under a coronal positioned flap to obtain root coverage.
Sponsors
Mayo Clinic
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
Bovine collagen matrix -PriMatrix
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes
Inclusion criteria
* Inclusion Criteria: * Adults 18-90 years of age * Miller Class I & II defects on maxillary or mandibular teeth * At least 1 adjacent non-involved tooth on either side of the included recession defects * Keratinized tissue width of ≥2.0 mm * Periodontal probing depths of 3 mm or on included teeth * Plaque index of 2 or less * Bleeding on probing at 30% or less sites * Current non-smoker * No active infected wounds *
Exclusion criteria
* Patients less than 18 years of age * Miller Class III, or IV mucogingival defects * Miller Class I & II defects without adjacent non-involved teeth * CEJ not identifiable * Root surface restoration at the defect site * Periodontal probing depths greater than 3 mm * Plaque index of 2 or greater * Bleeding on probing at more than 30% of sites * Uncontrolled oral disease * Moderate to severe generalized chronic or aggressive periodontitis * Oral manifestations of a systemic disease * History of previous root coverage procedure, graft, or GTR * Current smoker or other tobacco use * Alcohol abuse problems * Traumatic occlusion impinging on the recession defect * Use of intraoral appliances that impinge on the recession defect * Intra-oral piercings that impinge on the included defect * Uncontrolled systemic health conditions * Debilitating systemic or infectious disease * Diabetes * Heart Disease * Uncontrolled heart disease * Delayed wound healing * Immunocompromised status due to medication or immune system dysfunction * Active infection or non-healing wounds * Currently pregnant or lactating * Long-term steroid use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Complete Root Coverage | 6-months | The percentage of sites showing complete root coverage will be calculated as a percent of treated defects with the marginal gingival located at or above the cement-enamel junction compared to the total defects treated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pain Levels | 1-week, 2-weeks, 4-weeks, and 6-months | Visual analog scale questionnaire will be completed consisting of 5 to 6 questions at each appointment. |
| Mean Root Coverage Obtained | Baseline, 6-weeks, 4-months, and 6-months | Percentage of baseline root coverage obtained as a fraction of initial recession depth will be measured using a UNC-15 mm periodontal probe. |
| Clinical Periodontal Parameters | Baseline, 6-weeks, 4-months, and 6-months | Determine keratinized tissue width of the augmented region using a UNC-15 mm periodontal probe. |
| Plaque Levels | Baseline, 6-weeks, 4-months, and 6-months | Plaque levels will be evaluated using the Quigley and Hein plaque index. |
| Esthetic Outcomes | 1-week, 2-weeks, 4-weeks, and 6-months | Visual analog scale questionnaire will be completed consisting of 5 to 6 questions at each appointment. |
| Gingival Health | Baseline, 6-weeks, 4-months, and 6-months | Gingival health will be evaluated visually using Silness and Loe Gingival index. |
Countries
United States
Outcome results
None listed